The agreement brings together Resurrect Bio’s targeted approach to developing disease-resistance traits in crops with Bejo’s ...

Collaboration with intent to validate Cellares’ Cell Shuttle platform for manufacturing of CABA-201, Cabaletta Bio’s fully human CD19-CAR T product candidate, which is being evaluated in parallel ...

BIO-key’s chief revenue officer, Fred Corsentino, highlights the success of BIO-key’s Identity-Bound Biometrics platform as their partner program grows and adds more partners. As cyberattacks continue ...

Oncology-focused digital health company Flatiron Health announced it entered into a strategic partnership with Massive Bio, a company that helps cancer patients find and enroll in clinical trials.

AVANT BIO, a growth equity firm dedicated to the enabling technologies transforming tomorrow's therapeutics, today announced ...

The Ginkgo Technology Network brings together over 25 diverse partners across an array of capabilities including AI, genetic medicines, biologics, and manufacturing. As a Ginkgo Technology Network ...

MINNEAPOLIS, Jan. 30, 2026 /PRNewswire/ -- Pivot Bio, one of the world's leading innovative agtech companies, today announced it has been named Grand Farm Partner of the Year as part of Emerging ...

Cellino, a biotechnology firm working on autonomous biomanufacturing for personalized regenerative medicines, has signed a strategic collaboration with Karis Bio, a South Korean cell therapy company, ...

PHILADELPHIA, PA & BOSTON, MA — Tolerance Bio and ZipCode Bio have entered a strategic research and development collaboration to create novel delivery methods for thymus-targeted therapeutics, aiming ...

Overture Life, the global leader in automated IVF, and Spectrun Bio, a specialist in life sciences commercialization and clinical support across Brazil, today announced a strategic partnership to ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, ...

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--bit.bio, the company coding human cells for novel cures, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and ...